Noticias de CAPR_US | Rava Bursátil

24/08/2026 CAPR_US — Sahm

Capricor Therapeutics, Inc. Investor Alert - Robbins LLP Reminds CAPR Investors with Significant Losses of the Opportunity to Lead the Class Action Lawsuit Against the Company

24/08/2026 CAPR_US — MarketBeat

Capricor Therapeutics (CAPR) Institutional Ownership 2026

¿Qué accionistas están comprando/vendiendo acciones de Capricor Therapeutics (NASDAQ:CAPR)? Vea las transacciones de propiedad institucional CAPR (13F) en MarketBeat.

24/08/2026 CAPR_US — Williamson Herald

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit

24/08/2026 CAPR_US — Barchart.com

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

24/08/2026 CAPR_US — Barchart.com

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

23/08/2026 CAPR_US — Intellectia AI

Capricor's Deramiocel Faces Regulatory Challenges

23/08/2026 CAPR_US — The Globe and Mail

INVESTOR ALERT: Capricor Therapeutics, Inc. (CAPR) Securities Fraud Class Action Lawsuit Filed; September 28, 2026, Lead Plaintiff Deadline

Detailed price information for Capricor Therap (CAPR-Q) from The Globe and Mail including charting and trades.

23/08/2026 CAPR_US — Finimize ES ← EN

La terapia DMD de Capricor enfrenta una llamada de la FDA de alto riesgo

Capricor’s DMD Therapy Faces A High-Stakes FDA Call

23/08/2026 CAPR_US — ACCESS Newswire

CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!

23/08/2026 CAPR_US — nny360.com

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Nationally Recognized Firm Urges Capricor Investors to Explore Class Action Representation

23/08/2026 CAPR_US — lincolnjournal.com

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Nationally Recognized Firm Urges Capricor Investors to Explore Class Action Representation

22/08/2026 CAPR_US — TechStock²

Capricor’s FDA Delay Leaves a $2.20-a-Share Bet on Deramiocel

Capricor’s FDA Delay Leaves a $2.20-a-Share Bet on Deramiocel - TechStock²

22/08/2026 CAPR_US — FinancialContent

Capricor Therapeutics, Inc. - Common Stock (NQ: CAPR

View the latest news & press releases about Capricor Therapeutics, Inc. - Common Stock (Nasdaq:CAPR)

22/08/2026 CAPR_US — GlobeNewswire

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Capricor

22/08/2026 CAPR_US — ACCESS Newswire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

21/08/2026 CAPR_US — Morningstar

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR

21/08/2026 CAPR_US — PR Newswire

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR

/PRNewswire/ -- ClaimsFiler, un servicio GRATUITO de información para accionistas, recuerda a los inversores que tienen hasta el 28 de septiembre de 2026 para presentar al demandante principal...

21/08/2026 CAPR_US — ACCESS Newswire

September 28, 2026 Deadline Approaching: Join Class Action Against Capricor Therapeutics, Inc. (CAPR) - Contact Levi & Korsinsky

21/08/2026 CAPR_US — ACCESS Newswire

Securities Lawsuit Alert: Capricor Therapeutics, Inc. (CAPR) - Contact Levi & Korsinsky Before September 28, 2026

21/08/2026 CAPR_US — ACCESS Newswire

Levi & Korsinsky Notifies Capricor Therapeutics, Inc. (CAPR) Investors - Lead Plaintiff Deadline on September 28, 2026